Cargando…

New-Onset ANCA-Associated Vasculitis in a Patient with SARS-COV2

Detalles Bibliográficos
Autores principales:	Cobilinschi, Claudia, Cobilinschi, Cristian, Constantinescu, Alexandra, Draniceanu, Iuliana, Ionescu, Ruxandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Trakya University School of Medicine 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880889/ https://www.ncbi.nlm.nih.gov/pubmed/34558418 http://dx.doi.org/10.5152/balkanmedj.2021.21129

Ejemplares similares

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Increase in the number of new cases of ANCA-associated vasculitis in the COVID-19 vaccine era
por: Sato, Tomohito, et al.
Publicado: (2023)

Membranous glomerulonephritis with superimposed ANCA-associated vasculitis: another case report
por: Granata, Antonio, et al.
Publicado: (2011)

A case of ANCA-associated vasculitis after AZD1222 (Oxford–AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?
por: Villa, Miguel, et al.
Publicado: (2021)

Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis
por: Sethi, Amit, et al.
Publicado: (2023)

ANCA Associated Vasculitis Subtypes: Response [Letter]
por: Merkel, Peter A, et al.
Publicado: (2022)

COVID-19 vaccination precipitating de novo ANCA-associated vasculitis: clinical implications
por: Mai, Aaron Shengting, et al.
Publicado: (2022)

Adapted treatment of ANCA-associated vasculitis during the COVID-19 pandemic
por: Nimmo, Ailish, et al.
Publicado: (2021)

Frailty assessment in ANCA-associated vasculitis: current evidence and remaining uncertainties
por: Wang, Choon Ying, et al.
Publicado: (2022)

Cardiovascular risk assessment in lupus nephritis and ANCA-associated vasculitis in real-world nephrology practice
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Circulating B Cells, Plasma Cells, and Treg Associate with ANCA Levels in ANCA-associated Vasculitis
por: Manrique, Joaquin, et al.
Publicado: (2020)

Therapeutic Plasma Exchange: A Lifesaving Therapy in Case of ANCA-associated Vasculitis with Diffuse Alveolar Hemorrhage
por: Tripathi, Parmatma P, et al.
Publicado: (2021)

Rapid progression of atherosclerosis in a patient with acute coronary syndrome and ANCA-associated vasculitis: split or confluence?
por: LI, Ya-Chao, et al.
Publicado: (2022)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

ANCA Associated Vasculitis Subtypes: Response [Response to Letter]
por: Austin, Keziah, et al.
Publicado: (2022)

Clinicopathologic Findings in Mass Forming ANCA-Associated Vasculitis
por: Gilani, Sarwat I., et al.
Publicado: (2022)

The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis
por: van Leeuwen, Jolijn R, et al.
Publicado: (2023)

Leukocytoclastic Vasculitis and SARS-COV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Early and late ANCA vasculitis relapses after kidney transplantation may have different presentations
por: Masset, Christophe, et al.
Publicado: (2022)

Histopathological features of low-dose organophosphate exposure
por: Cobilinschi, Cristian, et al.
Publicado: (2020)

Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis
por: Goel, Ruchika, et al.
Publicado: (2021)

ANCA-associated Vasculitic Neuropathy Following Anti-SARS-CoV-2 Vaccination: An Epiphenomenon or Causal Association?
por: Jha, Shreyashi, et al.
Publicado: (2023)

Predictors of relapses in ANCA-associated small vessel vasculitis with kidney involvement
por: Iuliana, Andreiana, et al.
Publicado: (2014)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

The association between ambient UVB dose and ANCA-associated vasculitis relapse and onset
por: Scott, Jennifer, et al.
Publicado: (2022)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis
por: Knütter, Ilka, et al.
Publicado: (2012)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Avoidance of Harm From Treatment for ANCA-Associated Vasculitis
por: King, Catherine, et al.
Publicado: (2017)

Seasonal variations in the onset of positive and negative renal ANCA-associated vasculitis in Spain
por: Draibe, Juliana, et al.
Publicado: (2018)

Increased induction of de novo serum ANCA and ANCA-associated vasculitis after mass vaccination against SARS-CoV-2
por: Irure-Ventura, Juan, et al.
Publicado: (2022)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aprrn2cbr479f1nho3atsennv2